within Pharmacolibrary.Drugs.ATC.R;

model R05DA07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.00025,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R05DA07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Noscapine is a phthalideisoquinoline alkaloid found in the opium poppy, used as an antitussive (cough suppressant). It is not used for pain relief and has negligible narcotic effect. Noscapine is still available as an over-the-counter cough remedy in some countries, though it is not widely used or approved in the United States or Europe for this indication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Karlsson, MO, et al., &amp; Alm, AT (1990). Pharmacokinetics of oral noscapine. <i>European journal of clinical pharmacology</i> 39(3) 275–279. DOI:<a href=&quot;https://doi.org/10.1007/BF00315110&quot;>10.1007/BF00315110</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2257866/&quot;>https://pubmed.ncbi.nlm.nih.gov/2257866</a></p></li><li><p>Aneja, R, et al., &amp; Joshi, HC (2007). Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent. <i>Cancer chemotherapy and pharmacology</i> 60(6) 831–839. DOI:<a href=&quot;https://doi.org/10.1007/s00280-007-0430-y&quot;>10.1007/s00280-007-0430-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17285314/&quot;>https://pubmed.ncbi.nlm.nih.gov/17285314</a></p></li><li><p>Dahlström, B, et al., &amp; Johansson, M (1982). Pharmacokinetic properties of noscapine. <i>European journal of clinical pharmacology</i> 22(6) 535–539. DOI:<a href=&quot;https://doi.org/10.1007/BF00609627&quot;>10.1007/BF00609627</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7128665/&quot;>https://pubmed.ncbi.nlm.nih.gov/7128665</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R05DA07;
